Causeway Therapeutics

About:

Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health.

Website: http://www.causewaytherapeutics.com/

Top Investors: Scottish Investment Bank, Declan Doogan, Mediqventures, Glasgow University Holdings

Description:

Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health. It develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases.

Total Funding Amount:

9.75M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Glasgow, Glasgow City, United Kingdom

Founded Date:

2015-01-01

Founders:

Derek Gilchrist, Neal L Millar

Number of Employees:

1-10

Last Funding Date:

2023-02-22

IPO Status:

Private

Industries: